The Invus Group Revenue and Competitors

Claim your profile

Location

Total Funding

Industry

Estimated Revenue & Valuation

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Tuatara Capital	$3.5M	21	40%	N/A	N/A
#2 25madison	$7.5M	50	35%	N/A	N/A
#3 Icahn Enterpris...	$11830M	25025	5%	$1M	N/A
#4 Lee Equity Part...	$7.5M	41	5%	$48.1M	N/A
#5 Energy Impact P...	$15M	100	15%	N/A	N/A
#6 SVG	N/A	150	900%	N/A	N/A
#7 Thesis	N/A	20	300%	N/A	N/A
#8 Centre Lane Par...	$7.5M	48	26%	N/A	N/A
#9 Bullish	$3.5M	28	-7%	N/A	N/A
#10 43North	$3.5M	53	51%	N/A	N/A

Evergreen structure with over $5 billion under management. Offices in New York, Paris, and Hong Kong.

keywords:N/A

N/A

Total Funding

Number of Employees

$15M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

... Fidelity Management & Research Company, MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group,...

- Recurring revenues corresponding to royalties on sales received by the Group pursuant to the agreement with Biogen. In 2020, these revenues...

... and CEO of The Invus Group, LLC, a New York-based global investment firm. ... practices of its board of directors and executive team,...

... by founding investor Syncona and joined by important new investors including Forbion, Invus, Perceptive Advisors and Redmile Group.

Achilles Therapeutics, a UK biotech focusing on personalised immunotherapy for cancer, has closed a £100m Series B funding round that ...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Golf Magazine	$15.1M	69	-12%	N/A
#2 Laguarda.Low Ar...	$20.1M	69	-13%	N/A
#3 ACA Technology	$9M	69	30%	N/A
#4 MENTIS Software	$9M	69	19%	N/A
#5 Ironpaper	$15.5M	69	19%	N/A